% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Harvey:287630,
author = {C. Harvey and M. Weinreich$^*$ and J. A. K. Lee and A. C.
Shaw and L. Ferraiuolo and H. Mortiboys and S. Zhang and P.
J. Hop and R. A. J. Zwamborn and K. van Eijk and T. H.
Julian and T. Moll and A. Iacoangeli and A. Al Khleifat and
J. P. Quinn and A. L. Pfaff and S. Kõks and J. Poulton and
S. L. Battle and D. E. Arking and M. P. Snyder and J. H.
Veldink and K. P. Kenna and P. J. Shaw and J. Cooper-Knock},
collaboration = {P. M. A. S. Consortium},
title = {{R}are and common genetic determinants of mitochondrial
function determine severity but not risk of amyotrophic
lateral sclerosis.},
journal = {Heliyon},
volume = {10},
number = {3},
issn = {2405-8440},
address = {London [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2024-00284},
pages = {e24975},
year = {2024},
abstract = {Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease involving selective vulnerability
of energy-intensive motor neurons (MNs). It has been unclear
whether mitochondrial function is an upstream driver or a
downstream modifier of neurotoxicity. We separated upstream
genetic determinants of mitochondrial function, including
genetic variation within the mitochondrial genome or
autosomes; from downstream changeable factors including
mitochondrial DNA copy number (mtCN). Across three cohorts
including 6,437 ALS patients, we discovered that a set of
mitochondrial haplotypes, chosen because they are linked to
measurements of mitochondrial function, are a determinant of
ALS survival following disease onset, but do not modify ALS
risk. One particular haplotype appeared to be
neuroprotective and was significantly over-represented in
two cohorts of long-surviving ALS patients. Causal inference
for mitochondrial function was achievable using
mitochondrial haplotypes, but not autosomal SNPs in
traditional Mendelian randomization (MR). Furthermore, rare
loss-of-function genetic variants within, and reduced MN
expression of, ACADM and DNA2 lead to ∼50 $\%$ shorter ALS
survival; both proteins are implicated in mitochondrial
function. Both mtCN and cellular vulnerability are linked to
DNA2 function in ALS patient-derived neurons. Finally, MtCN
responds dynamically to the onset of ALS independently of
mitochondrial haplotype, and is correlated with disease
severity. We conclude that, based on the genetic measures we
have employed, mitochondrial function is a therapeutic
target for amelioration of disease severity but not
prevention of ALS.},
cin = {A230},
ddc = {000},
cid = {I:(DE-He78)A230-20160331},
pnm = {311 - Zellbiologie und Tumorbiologie (POF4-311)},
pid = {G:(DE-HGF)POF4-311},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38317984},
pmc = {pmc:PMC10839612},
doi = {10.1016/j.heliyon.2024.e24975},
url = {https://inrepo02.dkfz.de/record/287630},
}